Results 1 - 10 of 237

< 1 2 3 ... 23 24 >

• [DOI: 10.1021/jm0512894]
  
• Papadimitriou DT; Dermitzaki E; Papagianni M; Papaioannou G; Papaevangelou V; Papadimitriou A. Anastrozole plus leuprorelin in early maturing girls with compromised growth: the "GAIL" study., Journal of endocrinological investigation

  [DOI: 10.1007/s40618-015-0399-z]
  
• Maeda O; Moritani S; Ichihara S; Inoue T; Ishihara Y; Yamamoto S; Ito M; Matsumura Y; Sugiyama K; Horio M; Kondo I. Long-term survival in low-grade endometrial stromal sarcoma with childbirth and multidisciplinary treatment: a case report., Journal of medical case reports

  [DOI: 10.1186/s13256-015-0719-0]
  
• Percutaneous Absorption Enhancement of Leuprolide, Pharmaceutical Research

  [DOI: 10.1023/A:1015860324161]
  
• Synthesis of Leuprorelin Acetate, Pharmaceutical Chemistry Journal

  [DOI: 10.1007/s11094-014-1080-0]
  
• Degarelix: A Review of Its Use in Patients with Prostate Cancer, Drugs

  [DOI: 10.1007/s40265-014-0211-y]
  
• GnRH Antagonist: a New and an Effective Way of Treatment of Advanced Prostate Cancer, Indian Journal of Surgical Oncology

  [DOI: 10.1007/s13193-016-0611-4]
  
• A comparative study on the efficacies of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist in neoadjuvant androgen deprivation therapy combined with transperineal prostate brachytherapy for localized prostate cancer, BMC Cancer

  [DOI: 10.1186/s12885-016-2737-8]
  
• Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist, Basic and Clinical Andrology

  [DOI: 10.1186/s12610-015-0023-2]
  
• Wirksamkeit und Sicherheit von Degarelix: eine 12-monatige, vergleichende, randomisierte, Open-Label- und Parallelgrupen-Phase-III-Studie von Patienten mit Prostatakrebs, Der Onkologe

  [DOI: 10.1007/s00761-009-1653-9]